{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:11:08Z","timestamp":1774336268830,"version":"3.50.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00705-016-2907-7","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T17:11:44Z","timestamp":1464887504000},"page":"2087-2094","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Influenza virus neuraminidase (NA): a target for antivirals and vaccines"],"prefix":"10.1007","volume":"161","author":[{"given":"Anitha","family":"Jagadesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Ajees Abdul","family":"Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piya Paul","family":"Mudgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govindakarnavar","family":"Arunkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"2907_CR1","volume-title":"Fields\u2019 virology","author":"DM Knipe","year":"2007","unstructured":"Knipe DM, Howley PM (2007) Fields\u2019 virology. Lippincott Williams & Wilkins, Philadelphia"},{"key":"2907_CR2","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1073\/pnas.1116200109","volume":"109","author":"S Tong","year":"2012","unstructured":"Tong S, Li Y, Rivailler P et al (2012) A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci 109:4269\u20134274. doi:10.1073\/pnas.1116200109","journal-title":"Proc Natl Acad Sci"},{"key":"2907_CR3","doi-asserted-by":"publisher","first-page":"e1003657","DOI":"10.1371\/journal.ppat.1003657","volume":"9","author":"S Tong","year":"2013","unstructured":"Tong S, Zhu X, Li Y et al (2013) New world bats harbor diverse influenza A viruses. PLoS Pathog 9:e1003657","journal-title":"PLoS Pathog"},{"key":"2907_CR4","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3390\/v6062465","volume":"6","author":"T Wohlbold","year":"2014","unstructured":"Wohlbold T, Krammer F (2014) In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen. Viruses 6:2465\u20132494. doi:10.3390\/v6062465","journal-title":"Viruses"},{"key":"2907_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531\u2013569","journal-title":"Annu Rev Biochem"},{"key":"2907_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijid.2007.11.003","volume":"12","author":"G Pappas","year":"2008","unstructured":"Pappas G, Kiriaze IJ, Falagas ME (2008) Insights into infectious disease in the era of Hippocrates. Int J Infect Dis 12:347\u2013350. doi:10.1016\/j.ijid.2007.11.003","journal-title":"Int J Infect Dis"},{"key":"2907_CR7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3201\/eid1206.051263","volume":"12","author":"PM Martin","year":"2006","unstructured":"Martin PM, Martin-Granel E (2006) 2500-year evolution of the term epidemic. Emerg Infect Dis 12:976","journal-title":"Emerg Infect Dis"},{"key":"2907_CR8","unstructured":"Ageing AGD of H and history of pandemics. Australian Government Department of Health and Ageing. http:\/\/www.flupandemic.gov.au\/internet\/panflu\/publishing.nsf\/Content\/history-1"},{"key":"2907_CR9","unstructured":"Flu.gov pandemic flu history. http:\/\/www.flu.gov\/pandemic\/history\/. Accessed 10 Feb 2015"},{"key":"2907_CR10","unstructured":"WHO|Influenza (Seasonal). In: WHO. http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/. Accessed 14 Jun 2015"},{"key":"2907_CR11","unstructured":"WHO|Influenza. In: WHO. http:\/\/www.who.int\/biologicals\/vaccines\/influenza\/en\/. Accessed 20 Jun 2015"},{"key":"2907_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.6026\/97320630007076","volume":"7","author":"P Shil","year":"2011","unstructured":"Shil P, Chavan SS, Cherian SS (2011) Antigenic variability in Neuraminidase protein of Influenza A\/H3N2 vaccine strains (1968\u20132009). Bioinformation 7:76","journal-title":"Bioinformation"},{"key":"2907_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1750-2659.2011.00304.x","volume":"6","author":"GM Air","year":"2012","unstructured":"Air GM (2012) Influenza neuraminidase: influenza neuraminidase. Influenza Other Respir Viruses 6:245\u2013256. doi:10.1111\/j.1750-2659.2011.00304.x","journal-title":"Influenza Other Respir Viruses"},{"key":"2907_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/303035a0","volume":"303","author":"JN Varghese","year":"1983","unstructured":"Varghese JN, Laver WG, Colman PM (1983) Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 \u00c5 resolution. Nature 303:35\u201340. doi:10.1038\/303035a0","journal-title":"Nature"},{"key":"2907_CR15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/pro.5560031007","volume":"3","author":"PM Colman","year":"1994","unstructured":"Colman PM (1994) Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci 3:1687\u20131696","journal-title":"Protein Sci"},{"key":"2907_CR16","doi-asserted-by":"publisher","first-page":"12665","DOI":"10.1128\/JVI.78.22.12665-12667.2004","volume":"78","author":"MN Matrosovich","year":"2004","unstructured":"Matrosovich MN, Matrosovich TY, Gray T et al (2004) Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78:12665\u201312667. doi:10.1128\/JVI.78.22.12665-12667.2004","journal-title":"J Virol"},{"key":"2907_CR17","doi-asserted-by":"publisher","first-page":"e1002249","DOI":"10.1371\/journal.ppat.1002249","volume":"7","author":"CJ Vavricka","year":"2011","unstructured":"Vavricka CJ, Li Q, Wu Y et al (2011) Structural and functional analysis of laninamivir and its octanoate prodrug reveals group Specific mechanisms for influenza NA inhibition. PLoS Pathog 7:e1002249. doi:10.1371\/journal.ppat.1002249","journal-title":"PLoS Pathog"},{"key":"2907_CR18","unstructured":"Antiviral drug resistance among influenza viruses|health professionals|seasonal influenza (Flu). http:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/antiviral-drug-resistance.htm. Accessed 15 May 2015"},{"key":"2907_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/irv.12047","volume":"7","author":"JL McKimm-Breschkin","year":"2013","unstructured":"McKimm-Breschkin JL (2013) Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. Influenza Other Respir Viruses 7:25\u201336. doi:10.1111\/irv.12047","journal-title":"Influenza Other Respir Viruses"},{"key":"2907_CR20","unstructured":"Influenza antiviral medications: summary for clinicians|health professionals|seasonal influenza (Flu). http:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/summary-clinicians.htm. Accessed 15 May 2015"},{"key":"2907_CR21","unstructured":"Daiichi Sankyo receives approval to manufacture and market Inavir(R) influenza antiviral inhalant for treatment in Japan-Media & Investors-Daiichi Sankyo. http:\/\/www.daiichisankyo.com\/media_investors\/media_relations\/press_releases\/detail\/005703.html. Accessed 20 May 2015"},{"key":"2907_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/0-387-28146-0_17","volume-title":"Viral Membrane Proteins: Structure, Function, and Drug Design","author":"E Garman","year":"2005","unstructured":"Garman E, Laver G (2005) The structure, function, and inhibition of influenza virus neuraminidase. In: Fischer WB (ed) Viral Membrane Proteins: Structure, Function, and Drug Design. Springer, US, pp 247\u2013267"},{"key":"2907_CR23","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1128\/JVI.00959-08","volume":"82","author":"X Xu","year":"2008","unstructured":"Xu X, Zhu X, Dwek RA et al (2008) Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol 82:10493\u201310501. doi:10.1128\/JVI.00959-08","journal-title":"J Virol"},{"key":"2907_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","volume":"117","author":"E Takashita","year":"2015","unstructured":"Takashita E, Meijer A, Lackenby A et al (2015) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013\u20132014. Antiviral Res 117:27\u201338. doi:10.1016\/j.antiviral.2015.02.003","journal-title":"Antiviral Res"},{"key":"2907_CR25","unstructured":"Antiviral resistance surveillance in Japan (as of May 18, 2015). http:\/\/www.nih.go.jp\/niid\/en\/influ-resist-e\/5655-flu-dr-e20150518.html. Accessed 20 May 2015"},{"key":"2907_CR26","first-page":"733","volume":"2","author":"RL Malby","year":"1994","unstructured":"Malby RL, Tulip WR, Harley VR et al (1994) The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody. Struct Lond Engl 2:733\u2013746","journal-title":"Struct Lond Engl"},{"key":"2907_CR27","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jmb.2005.11.061","volume":"356","author":"L Venkatramani","year":"2006","unstructured":"Venkatramani L, Bochkareva E, Lee JT et al (2006) An epidemiologically significant epitope of a 1998 human influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex. J Mol Biol 356:651\u2013663. doi:10.1016\/j.jmb.2005.11.061","journal-title":"J Mol Biol"},{"key":"2907_CR28","doi-asserted-by":"publisher","first-page":"6114","DOI":"10.1038\/ncomms7114","volume":"6","author":"H Wan","year":"2015","unstructured":"Wan H, Yang H, Shore DA et al (2015) Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers. Nat Commun 6:6114. doi:10.1038\/ncomms7114","journal-title":"Nat Commun"},{"key":"2907_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0022-2836(92)90687-F","volume":"227","author":"WR Tulip","year":"1992","unstructured":"Tulip WR, Varghese JN, Laver WG et al (1992) Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. J Mol Biol 227:122\u2013148","journal-title":"J Mol Biol"},{"key":"2907_CR30","doi-asserted-by":"publisher","first-page":"12274","DOI":"10.1128\/JVI.76.23.12274-12280.2002","volume":"76","author":"U Gulati","year":"2002","unstructured":"Gulati U, Hwang C-C, Venkatramani L et al (2002) Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A\/Memphis\/31\/98). J Virol 76:12274\u201312280. doi:10.1128\/JVI.76.23.12274-12280.2002","journal-title":"J Virol"},{"key":"2907_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jmv.10143","volume":"67","author":"Y Abed","year":"2002","unstructured":"Abed Y, Hardy I, Li Y, Boivin G (2002) Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A: H3N2 viruses isolated in Canada. J Med Virol 67:589\u2013595","journal-title":"J Med Virol"},{"key":"2907_CR32","doi-asserted-by":"publisher","first-page":"20748","DOI":"10.1073\/pnas.1113801108","volume":"108","author":"MR Sandbulte","year":"2011","unstructured":"Sandbulte MR, Westgeest KB, Gao J et al (2011) Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc Natl Acad Sci 108:20748\u201320753. doi:10.1073\/pnas.1113801108","journal-title":"Proc Natl Acad Sci"},{"key":"2907_CR33","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1128\/JVI.02163-13","volume":"88","author":"KB Westgeest","year":"2014","unstructured":"Westgeest KB, Russell CA, Lin X et al (2014) Genomewide analysis of reassortment and evolution of human influenza A(H3N2) viruses circulating between 1968 and 2011. J Virol 88:2844\u20132857. doi:10.1128\/JVI.02163-13","journal-title":"J Virol"},{"key":"2907_CR34","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/jvi.2.8.778-786.1968","volume":"2","author":"JL Schulman","year":"1968","unstructured":"Schulman JL, Khakpour M, Kilbourne ED (1968) Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice. J Virol 2:778\u2013786","journal-title":"J Virol"},{"key":"2907_CR35","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0140-6736(73)92196-X","volume":"301","author":"A Monto","year":"1973","unstructured":"Monto A, Kendal A (1973) Effect of neuraminidase antibody on hong kong influenza. Lancet 301:623\u2013625. doi:10.1016\/S0140-6736(73)92196-X","journal-title":"Lancet"},{"key":"2907_CR36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/jvi.63.3.1239-1246.1989","volume":"63","author":"BE Johansson","year":"1989","unstructured":"Johansson BE, Bucher DJ, Kilbourne ED (1989) Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol 63:1239\u20131246","journal-title":"J Virol"},{"key":"2907_CR37","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0264-410X(01)00490-X","volume":"20","author":"BE Johansson","year":"2002","unstructured":"Johansson BE, Pokorny BA, Tiso VA (2002) Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition. Vaccine 20:1670\u20131674","journal-title":"Vaccine"},{"key":"2907_CR38","doi-asserted-by":"publisher","first-page":"6869","DOI":"10.1073\/pnas.84.19.6869","volume":"84","author":"BE Johansson","year":"1987","unstructured":"Johansson BE, Moran TM, Kilbourne ED (1987) Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proc Natl Acad Sci USA 84:6869\u20136873","journal-title":"Proc Natl Acad Sci USA"},{"key":"2907_CR39","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/0264-410X(95)00127-M","volume":"13","author":"ED Kilbourne","year":"1995","unstructured":"Kilbourne ED, Couch RB, Kasel JA et al (1995) Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans. Vaccine 13:1799\u20131803. doi:10.1016\/0264-410X(95)00127-M","journal-title":"Vaccine"},{"key":"2907_CR40","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/infdis\/jis935","volume":"207","author":"RB Couch","year":"2013","unstructured":"Couch RB, Atmar RL, Franco LM et al (2013) Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J Infect Dis 207:974\u2013981. doi:10.1093\/infdis\/jis935","journal-title":"J Infect Dis"},{"key":"2907_CR41","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/0264-410X(95)00126-L","volume":"13","author":"M Hocart","year":"1995","unstructured":"Hocart M, Grajower B, Donabedian A et al (1995) Preparation and characterization of a purified influenza virus neuraminidase vaccine. Vaccine 13:1793\u20131798","journal-title":"Vaccine"},{"key":"2907_CR42","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0264-410X(98)00247-3","volume":"17","author":"Z Chen","year":"1999","unstructured":"Chen Z, Matsuo K, Asanuma H et al (1999) Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 17:653\u2013659. doi:10.1016\/S0264-410X(98)00247-3","journal-title":"Vaccine"},{"key":"2907_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1089\/dna.2005.24.758","volume":"24","author":"F Zhang","year":"2005","unstructured":"Zhang F, Chen J, Fang F et al (2005) Maternal immunization with both hemagglutinin- and neuraminidase-expressing DNAs provides an enhanced protection against a lethal influenza virus challenge in infant and adult mice. DNA Cell Biol 24:758\u2013765. doi:10.1089\/dna.2005.24.758","journal-title":"DNA Cell Biol"},{"key":"2907_CR44","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01035-10","volume":"84","author":"BJ Bosch","year":"2010","unstructured":"Bosch BJ, Bodewes R, de Vries RP et al (2010) Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol 84:10366\u201310374. doi:10.1128\/JVI.01035-10","journal-title":"J Virol"},{"key":"2907_CR45","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1086\/381123","volume":"189","author":"ED Kilbourne","year":"2004","unstructured":"Kilbourne ED, Pokorny BA, Johansson B et al (2004) Protection of mice with recombinant influenza virus neuraminidase. J Infect Dis 189:459\u2013461","journal-title":"J Infect Dis"},{"key":"2907_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.virol.2005.06.006","volume":"339","author":"IC Brett","year":"2005","unstructured":"Brett IC, Johansson BE (2005) Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Virology 339:273\u2013280. doi:10.1016\/j.virol.2005.06.006","journal-title":"Virology"},{"key":"2907_CR47","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1016\/j.vaccine.2007.01.106","volume":"25","author":"RA Bright","year":"2007","unstructured":"Bright RA, Carter DM, Daniluk S et al (2007) Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 25:3871\u20133878. doi:10.1016\/j.vaccine.2007.01.106","journal-title":"Vaccine"},{"key":"2907_CR48","doi-asserted-by":"publisher","first-page":"e4667","DOI":"10.1371\/journal.pone.0004667","volume":"4","author":"S-M Kang","year":"2009","unstructured":"Kang S-M, Yoo D-G, Lipatov AS et al (2009) Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One 4:e4667. doi:10.1371\/journal.pone.0004667","journal-title":"PLoS One"},{"key":"2907_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jviromet.2014.09.003","volume":"210","author":"L Couzens","year":"2014","unstructured":"Couzens L, Gao J, Westgeest K et al (2014) An optimized enzyme-linked lectin assay to measure influenza A virus neuraminidase inhibition antibody titers in human sera. J Virol Methods 210:7\u201314. doi:10.1016\/j.jviromet.2014.09.003","journal-title":"J Virol Methods"},{"key":"2907_CR50","doi-asserted-by":"publisher","first-page":"e42363","DOI":"10.1371\/journal.pone.0042363","volume":"7","author":"C-Y Wu","year":"2012","unstructured":"Wu C-Y, Yeh Y-C, Chan J-T et al (2012) A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. PLoS One 7:e42363. doi:10.1371\/journal.pone.0042363","journal-title":"PLoS One"},{"key":"2907_CR51","doi-asserted-by":"publisher","first-page":"e17821","DOI":"10.1371\/journal.pone.0017821","volume":"6","author":"H Ding","year":"2011","unstructured":"Ding H, Tsai C, Zhou F et al (2011) Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus. PLoS One 6:e17821. doi:10.1371\/journal.pone.0017821","journal-title":"PLoS One"},{"key":"2907_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.virol.2012.05.006","volume":"430","author":"F-S Quan","year":"2012","unstructured":"Quan F-S, Kim M-C, Lee B-J et al (2012) Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection. Virology 430:127\u2013135. doi:10.1016\/j.virol.2012.05.006","journal-title":"Virology"},{"key":"2907_CR53","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.antiviral.2013.09.018","volume":"100","author":"TM Doyle","year":"2013","unstructured":"Doyle TM, Hashem AM, Li C et al (2013) Universal anti-neuraminidase antibody inhibiting all influenza A subtypes. Antiviral Res 100:567\u2013574. doi:10.1016\/j.antiviral.2013.09.018","journal-title":"Antiviral Res"},{"key":"2907_CR54","unstructured":"Prevention and control of seasonal influenza with vaccines. http:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr6207a1.htm#RecombinantInfluenzaVaccine. Accessed 12 Feb 2015"},{"key":"2907_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1749-6632.2010.05829.x","volume":"1217","author":"T Han","year":"2011","unstructured":"Han T, Marasco WA (2011) Structural basis of influenza virus neutralization. Ann N Y Acad Sci 1217:178\u2013190. doi:10.1111\/j.1749-6632.2010.05829.x","journal-title":"Ann N Y Acad Sci"},{"key":"2907_CR56","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1016\/j.vaccine.2009.02.084","volume":"27","author":"RA Bright","year":"2009","unstructured":"Bright RA, Neuzil KM, Pervikov Y, Palkonyay L (2009) WHO meeting on the role of neuraminidase in inducing protective immunity against influenza infection, Vilamoura, Portugal, September 14, 2008. Vaccine 27:6366\u20136369. doi:10.1016\/j.vaccine.2009.02.084","journal-title":"Vaccine"},{"key":"2907_CR57","unstructured":"WHO|WHO consultation and information meeting on the composition of influenza virus vaccines for the northern hemisphere 2015-2016. In: WHO. http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/consultation201502\/en\/. Accessed 30 Jun 2015"},{"key":"2907_CR58","unstructured":"HAN Archive-00374|Health Alert Network (HAN). http:\/\/emergency.cdc.gov\/han\/han00374.asp. Accessed 30 Jun 2015"},{"key":"2907_CR59","unstructured":"WHO|Recommended composition of influenza virus vaccines for use in the 2015-2016 northern hemisphere influenza season. In: WHO. http:\/\/www.who.int\/influenza\/vaccines\/virus\/recommendations\/2015_16_north\/en\/. Accessed 30 Jun 2015"},{"key":"2907_CR60","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.vaccine.2012.10.065","volume":"31","author":"RB Couch","year":"2012","unstructured":"Couch RB, Atmar RL, Keitel WA et al (2012) Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines. Vaccine 31:190\u2013195. doi:10.1016\/j.vaccine.2012.10.065","journal-title":"Vaccine"},{"key":"2907_CR61","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.vaccine.2014.01.078","volume":"32","author":"I Sultana","year":"2014","unstructured":"Sultana I, Yang K, Getie-Kebtie M et al (2014) Stability of neuraminidase in inactivated influenza vaccines. Vaccine 32:2225\u20132230. doi:10.1016\/j.vaccine.2014.01.078","journal-title":"Vaccine"},{"key":"2907_CR62","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/irv.12001","volume":"7","author":"M Getie-Kebtie","year":"2013","unstructured":"Getie-Kebtie M, Sultana I, Eichelberger M, Alterman M (2013) Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines: label-free mass spectrometry-based quantification of HA. Influenza Other Respir Viruses 7:521\u2013530. doi:10.1111\/irv.12001","journal-title":"Influenza Other Respir Viruses"},{"key":"2907_CR63","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1016\/j.vaccine.2011.12.056","volume":"30","author":"TL Williams","year":"2012","unstructured":"Williams TL, Pirkle JL, Barr JR (2012) Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry. Vaccine 30:2475\u20132482. doi:10.1016\/j.vaccine.2011.12.056","journal-title":"Vaccine"},{"key":"2907_CR64","doi-asserted-by":"publisher","first-page":"4762","DOI":"10.1016\/j.vaccine.2012.05.036","volume":"30","author":"MC Creskey","year":"2012","unstructured":"Creskey MC, Li C, Wang J et al (2012) Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC\u2013MSE. Vaccine 30:4762\u20134770. doi:10.1016\/j.vaccine.2012.05.036","journal-title":"Vaccine"},{"key":"2907_CR65","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.virusres.2009.04.005","volume":"143","author":"S-M Kang","year":"2009","unstructured":"Kang S-M, Song J-M, Quan F-S, Compans RW (2009) Influenza vaccines based on virus-like particles. Virus Res 143:140\u2013146. doi:10.1016\/j.virusres.2009.04.005","journal-title":"Virus Res"},{"key":"2907_CR66","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","volume":"31","author":"GE Smith","year":"2013","unstructured":"Smith GE, Flyer DC, Raghunandan R et al (2013) Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. Vaccine 31:4305\u20134313. doi:10.1016\/j.vaccine.2013.07.043","journal-title":"Vaccine"},{"key":"2907_CR67","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.7665","author":"F Behzadian","year":"2013","unstructured":"Behzadian F, Goodarzi Z, Fotouhi F, Saberfar E (2013) Baculoviral co-expression of HA, NA and M1 proteins of highly pathogenic H5N1 influenza virus in insect cells. Jundishapur J Microbiol. doi:10.5812\/jjm.7665","journal-title":"Jundishapur J Microbiol"},{"key":"2907_CR68","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1016\/j.vaccine.2010.06.044","volume":"28","author":"H Song","year":"2010","unstructured":"Song H, Wittman V, Byers A et al (2010) In vitro stimulation of human influenza-specific CD8+ T cells by dendritic cells pulsed with an influenza virus-like particle (VLP) vaccine. Vaccine 28:5524\u20135532. doi:10.1016\/j.vaccine.2010.06.044","journal-title":"Vaccine"},{"key":"2907_CR69","unstructured":"Flublok seasonal influenza (Flu) vaccine|seasonal influenza (Flu)|CDC. http:\/\/www.cdc.gov\/flu\/protect\/vaccine\/qa_flublok-vaccine.htm. Accessed 27 May 2015"},{"key":"2907_CR70","doi-asserted-by":"publisher","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","volume":"6","author":"TJ Wohlbold","year":"2015","unstructured":"Wohlbold TJ, Nachbagauer R, Xu H et al (2015) Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. mBio 6:e02556\u2013e02614. doi:10.1128\/mBio.02556-14","journal-title":"mBio"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-016-2907-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2907-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-016-2907-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:45:18Z","timestamp":1744173918000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-016-2907-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["2907"],"URL":"https:\/\/doi.org\/10.1007\/s00705-016-2907-7","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]},"assertion":[{"value":"19 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}